Cargando…
Prioritizing target-disease associations with novel safety and efficacy scoring methods
Biological target (commonly genes or proteins) identification is still largely a manual process, where experts manually try to collect and combine information from hundreds of data sources, ranging from scientific publications to omics databases. Targeting the wrong gene or protein will lead to fail...
Autores principales: | Failli, Mario, Paananen, Jussi, Fortino, Vittorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614395/ https://www.ncbi.nlm.nih.gov/pubmed/31285471 http://dx.doi.org/10.1038/s41598-019-46293-7 |
Ejemplares similares
-
Publisher Correction: Prioritizing target-disease associations with novel safety and efficacy scoring methods
por: Failli, Mario, et al.
Publicado: (2020) -
ThETA: transcriptome-driven efficacy estimates for gene-based TArget discovery
por: Failli, Mario, et al.
Publicado: (2020) -
An omics perspective on drug target discovery platforms
por: Paananen, Jussi, et al.
Publicado: (2019) -
A Robust and Accurate Method for Feature Selection and Prioritization from Multi-Class OMICs Data
por: Fortino, Vittorio, et al.
Publicado: (2014) -
Probabilistic prioritization of candidate pathway association with pathway score
por: Lin, Shu-Ju, et al.
Publicado: (2018)